| Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798) |
|---|
| 08/02/1995 | CN1105989A Tricyclic 1-aminoethylpyrrol derivative |
| 08/02/1995 | CN1105988A 1-amino-ethylindole-derivatives |
| 08/01/1995 | US5438068 Method of treating colon disturbances with pharmaceutical compositions containing imidazol-1-yl compounds |
| 08/01/1995 | US5437873 Superior tasting pharmaceutical composition having porous particles and the process of preparing such pharmaceutical composition |
| 08/01/1995 | US5437863 Administering interleukin-11,-6, leukemia inhibitory factor, oncostatin M or ciliary neurotrophic factor; regeneration of intestines, stomach, skin, hair sperm and liver cells; chemo- or radiation therapy |
| 08/01/1995 | CA2000911C Aqueous extract from pittosporaceae effective for diabetes and liver complaints and process for preparing the same |
| 08/01/1995 | CA1336516C Acyl derivatives of 2-amino-4-substituted-5-hydroxy pyrimidines |
| 08/01/1995 | CA1336495C Antacid compositions with prolonged gastric residence time |
| 07/27/1995 | WO1995019980A1 Pyrrolopyridazine derivative |
| 07/27/1995 | WO1995019978A1 Tetracyclic derivatives, process of preparation and use |
| 07/27/1995 | WO1995019970A1 Tricyclic compounds capable of inhibiting tyrosine kinases of the epidermal growth factor receptor family |
| 07/27/1995 | WO1995019961A1 Metalloproteinase inhibitors |
| 07/27/1995 | WO1995019959A1 Amino acid derivatives and their use as phospholipase a2 inhibitors |
| 07/27/1995 | WO1995019957A1 Hydroxamic acid derivatives as metalloproteinase inhibitors |
| 07/27/1995 | WO1995019956A1 Metalloproteinase inhibitors |
| 07/27/1995 | WO1995019952A1 Nitroxy group-containing benzylamine derivatives and their use for treating cardiovascular diseases, as well as increased intra-ocular pressure |
| 07/27/1995 | WO1995019774A1 Bicyclic compounds capable of inhibiting tyrosine kinases of the epidermal growth factor receptor family |
| 07/27/1995 | CA2181709A1 Hydroxamic acid derivatives as metalloproteinase inhibitors |
| 07/27/1995 | CA2181581A1 Nitroxy group-containing benzylamine derivatives and their use for treating cardiovascular diseases, as well as increased intra-ocular pressure |
| 07/27/1995 | CA2177372A1 Bicyclic compounds capable of inhibiting tyrosine kinases of the epidermal growth factor receptor family |
| 07/26/1995 | EP0664127A2 Pharmaceutical compositions containing isoquinoline derivatives |
| 07/26/1995 | EP0502092B1 Oral composition for the treatment of inflammatory bowel diseases |
| 07/26/1995 | CN1105581A Yinhuang Ganfu powder for curing hepatitis |
| 07/25/1995 | US5436348 Sleep disorders |
| 07/25/1995 | US5436258 Prevention of bone resorption |
| 07/25/1995 | US5436169 Protein associated with acute pancreatitis agents for the screening of acute pancreatitis |
| 07/25/1995 | US5436126 Synthetic peptides specific for the detection of antibodies to HCV, diagnosis of HCV infection and prevention thereof as vaccines |
| 07/20/1995 | WO1995019433A2 Anti-hepatitis b poly- and oligonucleotides |
| 07/20/1995 | WO1995019431A1 Zinc finger protein derivatives and methods therefor |
| 07/20/1995 | WO1995019429A2 Method and reagent for inhibiting hepatitis c virus replication |
| 07/20/1995 | WO1995019372A1 Biologically active peptides from functional domains of bactericidal/permeability-increasing protein and uses thereof |
| 07/20/1995 | WO1995019344A1 Gem-disubstituted azacyclic tachykinin antagonists |
| 07/20/1995 | WO1995019181A1 A METHOD OF TREATMENT OF PARASITIC INFECTION USING IgE ANTAGONISTS |
| 07/20/1995 | WO1995019170A1 Application of riluzole in the treatment of mitochondrial diseases |
| 07/20/1995 | CA2180746A1 Gem-disubstituted azacyclic tachykinin antagonists |
| 07/20/1995 | CA2180740A1 Method and reagent for inhibiting hepatitis c virus replication |
| 07/20/1995 | CA2180347A1 Anti-hepatitis b poly- and oligonucleotides |
| 07/19/1995 | EP0663400A1 Polyisoprene compounds, salts thereof, process for the preparation thereof, and use thereof |
| 07/19/1995 | EP0662959A1 5-ht4 antagonists |
| 07/19/1995 | EP0662827A1 Therapeutic and diagnostic methods and compositions based on notch proteins and nucleic acids |
| 07/19/1995 | EP0662821A1 Calcium polycarbophil sprinkle |
| 07/19/1995 | CN1105271A Pharmaceutical composition and process |
| 07/19/1995 | CN1105260A Powder for fast painless tooth extraction and producing process thereof |
| 07/18/1995 | US5434174 Isoxazole derivatives for the treatment of irritable bowel syndrome |
| 07/18/1995 | US5434171 Preparation of 3,4,4-trisubstituted-piperidinyl-N-alkylcarboxylates and intermediates |
| 07/18/1995 | US5434160 Autoimmune diseases; prevention of excess cell proliferation or enzyme release |
| 07/18/1995 | US5434158 Asthma |
| 07/18/1995 | CA1336321C Methods for prevention and treatment of mucositis with granulocyte colony stimulating factor |
| 07/13/1995 | WO1995018854A1 Ribozymes targeting the retroviral packaging sequence expression constructs and recombinant retroviruses containing such constructs |
| 07/13/1995 | WO1995018824A1 ISOLATED p27 PROTEIN AND ITS ENCODING NUCLEIC ACID MOLECULES |
| 07/13/1995 | WO1995018820A1 Monomeric diols and phosphate linked oligomers formed therefrom |
| 07/13/1995 | WO1995018793A1 Novel heterocyclic compounds |
| 07/13/1995 | WO1995018615A1 A method of treating neurogenic inflammation |
| 07/13/1995 | WO1995018610A1 Compounds and methods for the treatment of cardiovascular, inflammatory and immune disorders |
| 07/13/1995 | WO1995016035A3 Bmp-12, bmp-13 and tendon-inducing compositions thereof |
| 07/13/1995 | CA2180358A1 Ribozymes targeting the retroviral packaging sequence expression constructs and recombinant retroviruses containing such constructs |
| 07/13/1995 | CA2180239A1 A method of treating neurogenic inflammation |
| 07/13/1995 | CA2180238A1 Novel heterocyclic compounds |
| 07/13/1995 | CA2180123A1 Compounds and methods for the treatment of cardiovascular, inflammatory and immune disorders |
| 07/12/1995 | EP0662471A2 Naphthalene derivatives with affinity to the receptors of melatonine, process for their preparation and pharmaceutical compositions containing them |
| 07/12/1995 | EP0662087A1 Retinal pigmented epithelium derived neurotrophic factor |
| 07/12/1995 | EP0661992A1 Pharmaceutical formulations of interleukin-1 inhibitors |
| 07/12/1995 | EP0661990A1 Method for systemic treatment of catabolic conditions and systemic tissue injury |
| 07/12/1995 | EP0661987A1 Morphogen-induced liver regeneration |
| 07/12/1995 | EP0661966A1 Ulcer prevention and treatment composition and method |
| 07/12/1995 | EP0463139B1 2,13-disubstituted ergolins, their preparation and their use in drugs |
| 07/12/1995 | CN1104890A Cation-complexed polysacharides |
| 07/12/1995 | CN1029314C Substituted thiophenoimidazole derivative process for preparing same, pharmaceutical composition containing same and used as gastric acid secretive inhibitor |
| 07/11/1995 | US5432181 Substituted heteroaryl analogs of 4,6-di-tertiary-butyl-5-hydroxy-1,3-pyrimidines useful as antiinflammatory agents |
| 07/11/1995 | US5432156 Therapeutic agent for digestive tract diseases |
| 07/11/1995 | CA1336264C Pharmaceutical compositions containing deoxyribonucleosides for wound healing |
| 07/11/1995 | CA1336263C 4-quinoline carboxylic acid derivatives useful for treating skin and muco-epithelial diseases |
| 07/06/1995 | WO1995018131A1 New ginkgolide derivatives and a process for preparing them |
| 07/06/1995 | WO1995018129A1 Diazabicyclic neurokinin antagonists |
| 07/06/1995 | WO1995018128A1 Pyrazolopyridine adenosine antagonists |
| 07/06/1995 | WO1995018126A1 Furylthiazole and their use as h2-receptor antagonism and antimicrobial |
| 07/06/1995 | WO1995018124A1 Substituted morpholine derivatives and their use as therapeutic agents |
| 07/06/1995 | WO1995018105A1 1,3-dihydroindol-2-one derivatives substituted in position 3 by a nitrogen group as vasopressin and/or ocytocine agonists and/or antagonists |
| 07/06/1995 | WO1995017906A1 Dna encoding a human neuropeptide y/peptide yy/pancreatic polypeptide receptor (y4) and uses thereof |
| 07/06/1995 | WO1995017905A1 Ileal bile acid transporter compositions and methods |
| 07/06/1995 | WO1995017904A2 Botulinum toxins for treating various disorders and associated pain |
| 07/06/1995 | CA2682117A1 The use of the neurotoxic component of a botulinum toxin for the treatment of a facial disease, disorder or condition |
| 07/06/1995 | CA2180359A1 Ileal bile acid transporter compositions and methods |
| 07/06/1995 | CA2180253A1 Pyrazolopyridine adenosine antagonists |
| 07/06/1995 | CA2177736A1 New ginkgolide derivatives and a process for preparing them |
| 07/05/1995 | EP0661269A1 Substituted heterocyclic carboxylic acid amides, their preparation and their use as medicaments |
| 07/05/1995 | EP0661053A1 Use of tocopherol ascorbic adic phosphates for hemorrhoidal diseases |
| 07/05/1995 | EP0660719A1 Method and composition for ameliorating tissue damage due to ischemia and reperfusion |
| 07/05/1995 | EP0660716A1 Non-acidic cyclopentane heptanoic acid, 2-cycloalkyl or arylalkyl derivatives as therapeutic agents |
| 07/05/1995 | EP0660711A1 Novel use of inhibitors of phosphodiestersase iv |
| 07/04/1995 | US5430116 Polymers and oligomers of bile acid derivatives, process for their preparation and their use as pharmaceuticals |
| 07/04/1995 | US5430042 Dialkoxy-pyridinyl-benzimidazole derivatives, process for their preparation and their pharmaceutical use |
| 07/04/1995 | US5430031 Serotoninergic ergoline derivatives |
| 07/01/1995 | CA2138929A1 Substituted heterocyclic carboxamides, their preparation and their use as pharmaceuticals |
| 06/30/1995 | CA2139209A1 Therapeutic agent for hemorrhoidal diseases |
| 06/29/1995 | WO1995017414A1 Anti-hepatitis b viral oligonucleotides |
| 06/29/1995 | WO1995017402A1 New pyridazino[4',5':3,4]pyrrolo-[2,1-a]isoquinolines and their use for preparing pharmaceutical compositions |
| 06/29/1995 | WO1995017401A1 Dyhydrobenzofuranyl-biphenyl carboxamides having 5ht1d antagonistic activity |
| 06/29/1995 | WO1995017399A1 Trisubstituted phenyl derivatives, processes for their preparation and their use as phosphodiesterase (type iv) inhibitors |
| 06/29/1995 | WO1995017398A1 Indole, indoline and quinoline derivatives with 5ht1d (anti-depressive) activity |